372 related articles for article (PubMed ID: 33227992)
1. Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling.
Chu IR; Pan RL; Yang CS
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33227992
[No Abstract] [Full Text] [Related]
2. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.
König C; Morch E; Eitner A; Möller C; Turnquist B; Schaible HG; Ebersberger A
J Neurosci; 2016 Sep; 36(38):9782-91. PubMed ID: 27656018
[TBL] [Abstract][Full Text] [Related]
3. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta and catecholamines synergistically stimulate interleukin-6 release from rat C6 glioma cells in vitro: a potential role for lysophosphatidylcholine.
Zumwalt JW; Thunstrom BJ; Spangelo BL
Endocrinology; 1999 Feb; 140(2):888-96. PubMed ID: 9927320
[TBL] [Abstract][Full Text] [Related]
6. Modulation of TNF-alpha mRNA production in rat C6 glioma cells by TNF-alpha, IL-1beta, IL-6, and IFN-alpha: in vitro analysis of cytokine-cytokine interactions.
Gayle D; Ilyin SE; Miele ME; Plata-Salamán CR
Brain Res Bull; 1998 Oct; 47(3):231-5. PubMed ID: 9865855
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
[TBL] [Abstract][Full Text] [Related]
8. cAMP-induced astrocytic differentiation of C6 glioma cells is mediated by autocrine interleukin-6.
Takanaga H; Yoshitake T; Hara S; Yamasaki C; Kunimoto M
J Biol Chem; 2004 Apr; 279(15):15441-7. PubMed ID: 14754894
[TBL] [Abstract][Full Text] [Related]
9. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid apigenin from Croton betulaster Mull inhibits proliferation, induces differentiation and regulates the inflammatory profile of glioma cells.
Coelho PL; Oliveira MN; da Silva AB; Pitanga BP; Silva VD; Faria GP; Sampaio GP; Costa Mde F; Braga-de-Souza S; Costa SL
Anticancer Drugs; 2016 Nov; 27(10):960-9. PubMed ID: 27622606
[TBL] [Abstract][Full Text] [Related]
12. Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells.
Nakahata T; Sui X; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Tsuji K
Cancer Chemother Pharmacol; 1996; 38 Suppl():S64-8. PubMed ID: 8765420
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.
Van Wagoner NJ; Oh JW; Repovic P; Benveniste EN
J Neurosci; 1999 Jul; 19(13):5236-44. PubMed ID: 10377335
[TBL] [Abstract][Full Text] [Related]
14. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
[TBL] [Abstract][Full Text] [Related]
15. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
Erices A; Conget P; Rojas C; Minguell JJ
Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
[TBL] [Abstract][Full Text] [Related]
16. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC
Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor.
Mihara M; Moriya Y; Kishimoto T; Ohsugi Y
Br J Rheumatol; 1995 Apr; 34(4):321-5. PubMed ID: 7788145
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and tumour necrosis factor-α cooperatively promote cell cycle regulators and proliferate rheumatoid arthritis fibroblast-like synovial cells.
Kaneshiro K; Sakai Y; Suzuki K; Uchida K; Tateishi K; Terashima Y; Kawasaki Y; Shibanuma N; Yoshida K; Hashiramoto A
Scand J Rheumatol; 2019 Sep; 48(5):353-361. PubMed ID: 31631790
[No Abstract] [Full Text] [Related]
20. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
